Pharming Group (FRA:PHGN) Total Stockholders Equity : €197.9 Mil (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Pharming Group Total Stockholders Equity?

Pharming Group's Total Stockholders Equity for the quarter that ended in Mar. 2025 was €197.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Pharming Group's Book Value per Share for the quarter that ended in Mar. 2025 was €0.29. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Pharming Group's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.56.

Pharming Group Total Stockholders Equity Historical Data

The historical data trend for Pharming Group's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group Total Stockholders Equity Chart

Pharming Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

150.78

170.73

193.18

200.62

211.11

Pharming Group Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															189.47	205.25	203.44	211.11	197.95

Pharming Group (FRA:PHGN) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Pharming Group's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(197.948	-	0)	/	683.931
	=	0.29

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Pharming Group's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(8.129	+	102.078)	/	197.948
	=	0.56

Pharming Group Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Pharming Group's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharming Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (FRA:PHGN) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

PHAR:USA PHGUF:USA PHARM:Netherlands PHARMa:UK 0QCO:UK

Address

Darwinweg 24, Leiden, ZH, NLD, 2333 CR

Website

https://www.pharming.com

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Pharming Group Headlines

No Headlines